AstraZeneca lupus treatment Saphnelo obtains FDA approval
The drug, intended for adult patients with moderate-to-severe systemic lupus erythematosus, is the only new therapy approved for SLE in more than a decade.
Archives for August 2, 2021
Treg cell therapy showing promise in ALS trials: Coya Therapeutics
According to the neurodegenerative-disease-focused biotechnology firm, their research could bring hope to patients with amyotrophic lateral sclerosis.
Moderna takes first autoimmune therapeutic candidate into the clinic
Moderna has dosed the first participant in a Phase 1 study of its IL-2 mRNA therapeutic, mRNA-6231.
Arcturus Therapeutics lines up Phase 1/2/3 trial for next-generation mRNA COVID-19 vaccine
Arcturus Therapeutics and its Vietnam partner Vinbiocare will take ARCT-154, a next-generation Arcturus vaccine targeting SARS-CoV-2 variants of concern, into a Phase 1/2/3 trial. The companies will also establish a vaccine manufacturing centre in Vietnam.
Could DNA-based COVID-19 vaccine offer variant-busting booster shot?
With Scancell taking its DNA-based COVID-19 vaccine tech into clinical trials this year, it is already focusing its attention on the tech’s potential to be used as a needle-free booster shot to address Variants of Concern.
Sartorius downplays threat of Chinese regulatory changes to single-use tech
Sartorius has expressed confidence that demand for single-use technologies will be unaffected by changes to the regulation of biologics in China.
Pfizer-BioNTech COVID-19 vaccine outperforms Sinovac jab in antibody study
The mRNA vaccine developed by Pfizer and BioNTech generates far higher levels of antibodies against the coronavirus than Sinovac’s inactivated virus prophylactic, according to a study.